Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Nascimento LF et al. | 2003 | bacterium, <i>Escherichia coli</i>/ATCC 25922 | magnetic field, 50/60 Hz | 500 µT |
Pang L et al. | 2002 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 4.4–13 mT |
Yoshizawa H et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia), MCF-7 (breast carcinoma), A-375 (malignant melanoma), H4 (glioma) | magnetic field, low frequency, 50/60 Hz | 2–500 µT |
Manni V et al. | 2002 | intact cell/cell culture, HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz | 2 mT |
Tian F et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells (Ku80-proficient) und xrs5 cells (Ku80-defizient; radiation sensitive mutant isolated from CHO-K1 cells) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Fedrowitz M et al. | 2002 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, source not given | 100 µT |
Strasak L et al. | 2002 | bacterium, <i>Escherichia coli</i> | magnetic field, 50/60 Hz | 2.7–10 mT |
Glück B et al. | 2001 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, 50/60 Hz | 0.3–4.5 mT |
Jacobi-Elizondo JS et al. | 2001 | intact cell/cell culture, L5178Y-R cells (mouse lymphoma cell line), animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 1 mT |
Johnson MT et al. | 2001 | intact cell/cell culture, lymphocytes from the peripheral blood of humans and rat, whole body | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 0.1–1.8 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.